0000357097-15-000052.txt : 20150602 0000357097-15-000052.hdr.sgml : 20150602 20150602160611 ACCESSION NUMBER: 0000357097-15-000052 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150601 FILED AS OF DATE: 20150602 DATE AS OF CHANGE: 20150602 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Fibrocell Science, Inc. CENTRAL INDEX KEY: 0000357097 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 870458888 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 405 EAGLEVIEW BOULEVARD CITY: EXTON STATE: PA ZIP: 19341 BUSINESS PHONE: 484-713-6000 MAIL ADDRESS: STREET 1: 405 EAGLEVIEW BOULEVARD CITY: EXTON STATE: PA ZIP: 19341 FORMER COMPANY: FORMER CONFORMED NAME: ISOLAGEN INC DATE OF NAME CHANGE: 20020320 FORMER COMPANY: FORMER CONFORMED NAME: AMERICAN FINANCIAL HOLDING INC /DE DATE OF NAME CHANGE: 19960330 FORMER COMPANY: FORMER CONFORMED NAME: AMERICAN FINANCIAL HOLDING INC /CO DATE OF NAME CHANGE: 19921008 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Marino Michael F III CENTRAL INDEX KEY: 0001502700 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-31564 FILM NUMBER: 15906934 MAIL ADDRESS: STREET 1: C/O NUPATHE, INC. STREET 2: 227 WASHINGTON STREET, SUITE 200 CITY: CONSHOHOCKEN STATE: PA ZIP: 19428 4 1 wf-form4_143327555865021.xml FORM 4 X0306 4 2015-06-01 0 0000357097 Fibrocell Science, Inc. FCSC 0001502700 Marino Michael F III FIBROCELL SCIENCE, INC. 405 EAGLEVIEW BOULEVARD EXTON PA 19341 0 1 0 0 SVP and General Counsel Option to Purchase Common Stock 4.76 2015-06-01 4 A 0 220000 A 2025-06-01 Common Stock 220000.0 220000 D The options set forth in this table vest as follows: (i) 55,000 shares on June 1, 2016 and (ii) 13,750 for each of twelve quarterly installments beginning on September 1, 2016 and ending on June 1, 2019 provided the reporting person is employed by the Company on each vesting date. The options were issued in connection with the reporting person's employment service to the Company. /s/ Michael F. Marino 2015-06-02